SEC Form 4 · accession 0001209191-15-077676

STERIS CORP · STE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr. V.P., Procedural Solutions

Period of report

Nov 2, 2015

Accepted (ET)

Nov 2, 2015 · 4:03 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000815065

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares, No Par Value^F1,F2	Nov 2, 2015	D	7,000	—	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F3	$65.05	Nov 2, 2015	D	11,700	D	—	Aug 27, 2025	Common Shares, No Par Value	11,700	0	D

F1All 7,000 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 7,000 on May 28, 2019.
F2Represents shares of STERIS Corporation ("STERIS") disposed of pursuant to merger of a wholly-owned subsidiary of STERIS plc ("New STERIS") with and into STERIS, with STERIS surviving the merger as a wholly-owned subsidiary of New STERIS (the "Merger"), in exchange for ordinary shares of New STERIS, which was consummated simultaneous with and conditioned on New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law. At the effective time of the Merger, each STERIS common share was cancelled and converted into the right to receive one New STERIS ordinary share.
F3This option becomes exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was assumed by New STERIS in the Merger and converted to an option to purchase 11,700 ordinary shares of New STERIS for $65.05 per share, subject to the same terms and conditions that were applicable to the original STERIS option.